Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
Status:
Recruiting
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatments, alone
and in combination, for the treatment of loss-of-control eating and weight following
bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in
combination with combination naltrexone/bupropion medication.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)